chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm soreness; This is a spontaneous report from a contactable pharmacist (patient). A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on 23Dec2020 12:30 at a single dose for COVID prevention. Medical history included diabetic (On insulin only. Diabetic for six to seven years and have had no hypoglycemic events). There were no concomitant medications. It was reported that the patient experienced arm soreness on an unspecified date. The outcome of the event was unknown.
Patient presented to hospital with chest pain that began the morning of 1/20/2022. He recently received his COVID-19 booster vaccine 1/17/2022. EKG was performed in the ER, showed changes concerning for myocarditis. A chest x-ray was performed and did not show any pathology. An ECHO was also obtained and showed adequate cardiac function. Basic labs that were drawn were mostly within normal limits, other than a high troponin level of 9,913 ng/L. The patient was given ibuprofen 400mg Q6H and was monitored overnight.
I had two am Jan 9, chills, aches, low grade temperature. That lasted about 24 hours. Malaise -  extreme  -lasted the same amount of time. I took Tylenol twice.
Patient reports receiving Covid vaccination on May 8 and then  yesterday developed a cellulitic region in his left upper arm. He  states he uses his arms a lot at work. States the site became warm  and mildly tender. Denies any itching, difficulty breathing, fever.  He received this moderna vaccination at pharmacy.
A day after vaccination, I began to have a hard time breathing and chest pain. My parents drove me to the hospital- Emergency Room. I was admitted and given muscle relaxers and pain medication. They drew labs, also. They said the the lining of my chest and lungs has swelled.
Broke out in rash, itching, bumps all over body. Patient lives at a nursing home
THE PATIENT START TO EXPERINCE REDNESS AT THE SITE OF THE INJECTION WITH SOME FEVER. HOWEVER, 2 DAYS AFTER THE PATIENT HAD MORE FEVER AND HE VISITED HIS DOCTOR. AND THE DOCTOR HAS SENT HIM TO THE ER. WERE HE GOT DIAGNOSED WITH SKIN INFECTION AND HE SPENT 6 HOURS AT THE ER.
Fever                                          HA                                                  Tachycardia vomiting's chest pain  + 12 EKG- Pericarditis +Tropin Pt referred to Pedi Cardiology
Received the new flu shot that has the H1N1 vaccine included.  Not long after I got horribly sick, flu like symptoms.  Fever, horrible nausea, bad back aches as well as a large hard lump (about the size of a flattened golf ball) at the injection site and a very sore arm. Everything but the lump was gone within 24 hours.  The lump remains exactly the same 48 hours later with no signs of changing.
Tested positive on Covid, the disease; This spontaneous case was reported by a consumer and describes the occurrence of ASYMPTOMATIC COVID-19 (Tested positive on Covid, the disease) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced ASYMPTOMATIC COVID-19 (Tested positive on Covid, the disease). At the time of the report, ASYMPTOMATIC COVID-19 (Tested positive on Covid, the disease) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications was reported Treatment information was not provided
Chills; fever; achy all over; skin hurts to touch; very tired; This is a spontaneous report from a contactable consumer. A 46-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9264, Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 04Feb2021 07:30 (at the age of 46-years-old) as dose 2, single for covid-19 immunisation in hospital. Medical history included penicillin allergy. The patient's concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EK9231, Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 01Jan2021 07:30 (at the age of 46-years-old) as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 04Feb2021 at 14:00, the patient experienced chills, fever, achy all over, skin hurts to touch and very tired. Since the vaccination, the patient has not been tested for COVID-19. No treatment received for the adverse events. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Unexplained death within 24 hours of 4 month vaccines in the office. 3/26/07 Received Autopsy Report which reveals COD as SIDS.  Patient had colostomy in place s/p surgical formation of rectum at birth & site was considered unremarkable.  Child had been examined by PCP on 12/22/06 & received vax.  Found to be well at that time.
Pt had chest pain the day following her first dose of Moderna, and told me right before I gave her the second dose. I didn't administer the second dose.
Several hours after vaccination developed fever and seizure lasting more than 45 minutes. Admit to PICU for 24 hours PEDS 48 hours. Brought by ambulance to ER where got Atavan. Additional terms stated in Discharge summary rec'd 06/21/2005 -- Hyperglycemia and status epilepticus.
RED AND SWOLLEN. HOT TO TOUCH.  PAIN SO BAD, HAD TO TAKE A PAIN PILL TO GET SLEEP. SYMPTOMS LASTED 3 DAYS.
I believe vaccine was administered correctly. I developed a small patch of what appeared to be shingles rash 4 days after the vaccine was administered - about 20 pustules on one hip, 3 of which were moderately painful.  All but those 3 have cleared 4 weeks later, and those 3 are healing but still tender.
6.5cm red, slightly indurated left deltoid area noted 48 hours after administration of IPV, DTaP, to left deltoid. No nodule, ?
admitted for possible aspiration PNA on 12/7. Pt recently admitted 11/25-11/30 for COVID and received 3 doses of remdesivir and 10 days of decadron.
High heart rate, elevated blood pressure, numbness on right side of face, weakness, tightness in chest, mild dizziness, tension in right jaw and temple
One week after receiving the MMR vaccine a small bump apeared on the side of joint to the little finger on the right hand with mild stiffness and swelling. No pain or any other reaction verbalized. Client denied any trauma to finger. Referred for evaluation by M.D.
Vaccine was given at age 37 4/7 weeks. Not to be administered over 32 weeks of age.
I HAVE EXPERIENCED DIZZINESS FOR OVER A YEAR AND IT SEEMS TO BE GETTING WORSE.  I ALSO HAVE TINITUS WHICH IS GETTING WORSE.
Information has been received from a registered nurse, concerning a female patient, who on an unspecified date was vaccinated with GARDASIL. The registered nurse mentioned the patient developed a fever and Cellulitis like reaction after receiving her first of HPV vaccine. The patient sought medical attention and was seen at the physician's office. Additional information has been requested.
Moderna COVID-19 Vaccine EUA.  Swelling, redness, soreness, itching from the injection site to the elbow. Soreness began 10-11 hours after injection.  The injection site-related symptoms have progressed.  Had headache and chills followed by a low grade temperature within 24 hours of injection.  No longer experiencing any symptoms besides those associated with the upper left arm.  Will advise primary care physician of the issue today.
Pt recvd 2nd dose of Hep B vax 11JUL91 & following vax exp fever & chills x 1 wk & lethargy x 2 wks; pt recovered;
patient was ordered to receive pneumococcal vaccine on 17Aug2023 but she accidentally grabbed meningococcal vaccine Menveo and administered.; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 4-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA908A, expiry date 30-APR-2024) for prophylaxis.   On 17-AUG-2023, the patient received the 1st dose of Menveo. On 17-AUG-2023, an unknown time after receiving Menveo, the patient experienced wrong vaccine administered (Verbatim: patient was ordered to receive pneumococcal vaccine on 17Aug2023 but she accidentally grabbed meningococcal vaccine Menveo and administered.).  The outcome of the wrong vaccine administered was unknown.   Additional Information: GSK receipt date 28 August 2023: The nurse reported 4 year old the patient was ordered to receive pneumococcal vaccine but she accidentally grabbed meningococcal vaccine Menveo and administered.  She was aware the vaccine was approved for children as young as 2 months, but this patient was not at-risk, so normally would not be given Menveo until adolescence. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter. The patient accidentally grabbed meningococcal vaccine Menveo instead of pneumococcal vaccine which led to wrong vaccine administered.
Nausea vomiting hot flashes dizzyness fuzzy blur drunk like feeling heavy body no bowels for 5 dayz  but the worst of all is.. The swelling in my right foot the pain the throbbing hard ball like lumps stiffness redness and over all discomfort cant sleep without ice and been to doctors ever since ..
No AE/ PQC reported at this time.; improperly stored temperature excursion; patient date of birth: 8/12/2007; This spontaneous report has been received from a medical assistant and refers to a 13-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies, and concomitant medications were not reported.  On 24-JUN-2021, the patient was vaccinated with an improperly stored dose (product storage error) of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (dose, route of administration, vaccination scheme, anatomical site of vaccination were not reported, lot number T027112 has been verified to be valid, expiration date 07-FEB-2022) as prophylaxis (product administered to patient of inappropriate age).   The vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (lot number T027112, expiration date 07-FEB-2022) was exposed to the temperature excursion of 10 Fahrenheit degrees during a time frame of 7 hours. It was reported a previous temperature excursion of 6.10 Fahrenheit degrees during a time frame of 1 hour and 30 minutes. These temperature excursions were not detected by a data logger.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2107USA000296:
Patient received first vaccine on 1.27.2021. On 1/27/21, patient states her skin starting burning and had diffuse itching all over her body. Patient also experienced extreme arm soreness that lasted around 6 days. Patient has mostly recovered, just has a red mark remaining on her arm.
first dose of Shingrix on 1/2/20 and the second dose on 8/11/20; full body rash; swelling; chills; body aches; fever over 100 degrees; This case was reported by a nurse via call center representative and described the occurrence of generalized rash in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 34RS7, expiry date 6th February 2022) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 2nd January 2020).   On 11th August 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 11th August 2020, less than an hour after receiving Shingrix, the patient experienced generalized rash, swelling, chills, general body pain, fever and drug dose administration interval too long. The patient was treated with prednisone and benadryl (nos) (Benadryl). In August 2020, the outcome of the generalized rash, swelling, chills, general body pain and fever were recovered/resolved. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the generalized rash, swelling, chills, general body pain and fever to be related to Shingrix.  Additional details were reported as follows: The patient received the second dose of Shingrix in right deltoid and within 15 minutes the patient had a full body rash, fever over 100 degrees F, body aches, chills, and swelling. The reporter reported these events lasted 2 to 3 days and then resolved. The patient was treated with Prednisone and Benadryl for these events. The reporter did not consent to follow-up. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule. This is 1 of the 4 cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020211992:same reporter US-GLAXOSMITHKLINE-US2020211994:same reporter US-GLAXOSMITHKLINE-US2020211989:same reporter
This spontaneous report was received from a certified medical assistant (healthcare worker) refers to a patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 12-JAN-2016, the patient was vaccinated with an improperly stored VAQTA lot # L023232, 25-FEB-2017. This is one of the several reports received from the same reporter. Additional information has been requested.
Cellulitis of left upper limp. Treated with Keflex 500 mg 1 tablet every 12 hours for 5 days.
10 patients received Moderna vaccine that had thawed out and then refroze; 10 patients received Moderna vaccine that had thawed out and then refroze; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (10 patients received Moderna vaccine that had thawed out and then refroze), PRODUCT STORAGE ERROR (10 patients received Moderna vaccine that had thawed out and then refroze) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (10 patients received Moderna vaccine that had thawed out and then refroze), PRODUCT STORAGE ERROR (10 patients received Moderna vaccine that had thawed out and then refroze) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (10 patients received Moderna vaccine that had thawed out and then refroze), PRODUCT STORAGE ERROR (10 patients received Moderna vaccine that had thawed out and then refroze) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (10 patients received Moderna vaccine that had thawed out and then refroze) and PRODUCT STORAGE ERROR (10 patients received Moderna vaccine that had thawed out and then refroze).    No concomitant medications were reported. It was reported as unknown that patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. The patients have not reported other side effects.  No treatment medications were reported.  This case contains information for the 01 of 10 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-743068, US-MODERNATX, INC.-MOD-2023-743074, US-MODERNATX, INC.-MOD-2023-743085, US-MODERNATX, INC.-MOD-2023-743075, US-MODERNATX, INC.-MOD-2023-743079, US-MODERNATX, INC.-MOD-2023-743084, US-MODERNATX, INC.-MOD-2023-743083, US-MODERNATX, INC.-MOD-2023-743082, US-MODERNATX, INC.-MOD-2023-743080 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-743068:Patient 2 US-MODERNATX, INC.-MOD-2023-743079:Patient 5 US-MODERNATX, INC.-MOD-2023-743083:Patient 8 US-MODERNATX, INC.-MOD-2023-743085:Patient 10 US-MODERNATX, INC.-MOD-2023-743082:Patient 7 US-MODERNATX, INC.-MOD-2023-743074:Patient 3 US-MODERNATX, INC.-MOD-2023-743075:Patient 4 US-MODERNATX, INC.-MOD-2023-743080:Patient 6 US-MODERNATX, INC.-MOD-2023-743084:Patient 9
Immunization was given on 12/12/2000; weight 11lbs 10ozs, temperature 97.0. The infant died of SIDS on 12//23/2000.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 05/7/21 pfizer,Lot#EWO170 2nd dose: 05/28/21Pfizer,Lot# EK8734 Diagnosed covid positive:07/28/21 Symptom onset:07/28/21 Exposure:Travel Symptoms:Asymptomatic
On June 1, 2015, M.A. mixed vaccines and administered to patient a MENVEO and Tdap vaccine. It was later discovered that she had mixed the powder component of the MENVEO with a Tdap vaccine and also administered and extra Tdap vaccine. Instead of pulling out the liquid portion of the MENVEO, she accidentally pulled out an extra Tdap vaccine. When notified of this error I immediately contacted the CDC information line at 1-800-CDC-INFO. Spoke with person and gave explanation of the error that was made. She explained that there were no serious side effects of the error but if given closely together then may have a more prominent local reaction. She advised that she would forward to the vaccine specialist to verify but was sure of her advice. Received an email on June 2, 2015 from MD which verified person's information. (Copy of this email is in scanned documents in the chart) -- Dr. was informed of the error and response from the CDC. On June 3, 2015, MA was given a written warning for her error and patient's mother was notified. --- There is a language barrier because mom does not speak English. Was asked to come to the office the next day because patient would have to be revaccinated for the MENVEO since only one component was received. --- On June 4, 2015, patient and her mother returned to the office. Dr., with an interpreter, explained the error in detail and MA apologized for her mistake. Mother of patient expressed to Dr that she trusted him and understood that mistakes happen. She was very appreciative of Dr explaining everything to her and that there was no serious side effects from this error. Patient was given another MENVEO vaccine with both power and liquid components to make sure she had maximum meningococcal coverage. Error was reported to VAERS as directed by the CDC.
Patient's mother called, states daughter got the second dose of the Meningitis Vaccine on 9/28/2022 in right arm. That evening she started to not feel good. Started with a rash and arm got discolored with a dark red color, swelling arm & shoulder area. By Friday started to go into armpit. Saturday the patient told mom the swelling and redness and warm to the touch has moved into the side of right breast towards the nipple.  She has been unable to sleep since Thursday night. Wednesday she was taking Benadryl for an allergic reaction.  Starting Thursday, she has been taking Tylenol and Motrin and she has been unable to sleep. Advised to go to ER, she was prescribed Cephalexin 500mg 1 tab every 6 hours, #28
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Oct2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 40 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; AMLOPINE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of drug ineffective, covid-19.The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.  Clinical course: Patient received vaccine and other medication (Linsinopril and amlopine) in 2 weeks. Covid vaccine lot no. was unknown due to other reason that was unable to access at the time.   The lot number for [BNT162B2], was not provided and will be requested during follow up.
About one minute after receiving PNEUMOVAX vaccine. Patients face was plushed, she started coughing and looked tense, cough continued for a few minutes, then subsided. She looked pale and when asked how she felt she said she "was wheezy". There was no wheezing, facial or upswelling. She denied having a itchy throat. Epipen was (0.3mg) administered, prednisolone 30g PO. She was transported by EMS in hospital. See attached for "time records".
side effects-almost like flu; bad abdominal pain; diarrhea; lack of energy; dizziness; headache; arm sore; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in September 2020.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced HEADACHE (headache). On 06-Jan-2021, HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment of the events included Advil (ibuprofen) and Aleve (naproxen).  This case concerns an 82-year-old female with NS events of unexpected pain in extremity, influenza like illness, asthenia, abdominal pain, diarrhea, dizziness and expected headache. Arm pain onset Day 1 after first dose mRNA-1273, followed by other events on Day 2. Treatment not reported. Events resolved, except asthenia ongoing. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.; Reporter's Comments: This case concerns an 82-year-old female with NS events of unexpected pain in extremity, influenza like illness, asthenia, abdominal pain, diarrhea, dizziness and expected headache. Arm pain onset Day 1 after first dose mRNA-1273, followed by other events on Day 2. Treatment not reported. Events resolved, except asthenia ongoing. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
19OCT92 pt recvd vax & 22OCT92 in the evening devel sx; pt is reported to be feeling fine; sx have resolved & no treatment was required;
I don't know if this is where I should report this. I am (original citizen), but live in (another country). I got all of my vaccines here. If there is somewhere else I should be reporting this, please let me know. I was 9 weeks pregnant when I got my 3rd covid shot. 2 weeks later I started having severe bleeding that lasted on and off throughout the rest of my pregnancy. My baby developed severe megacystis which got worse and worse, and I was eventually encouraged to terminate the pregnancy.